Salicylic acid/γ-cyclodextrin 2:1 and 4:1 complex formation by sealed-heating method

Journal of Pharmaceutical Sciences

Volumn 99, Issue 10, 2010, Pages 4192-4200

  Higashi, Kenjirou ^a   Tozuka, Yuichi ^b   Moribe, Kunikazu ^a   Yamamoto, Keiji ^a  

^a CHIBA UNIVERSITY   (Japan)

^b GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Complexation; Crystal structure; Cyclodextrins; FT IR; Sealed heating; Solid state NMR; Thermal analysis; Water sorption; X ray powder diffractometry

Indexed keywords

GAMMA CYCLODEXTRIN; SALICYLIC ACID;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; COMPLEX FORMATION; HEATING; INFRARED SPECTROSCOPY; WATER CONTENT; X RAY DIFFRACTION;

EID: 77957358323     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22133     Document Type: Article

References (40)

1. Brewster ME, Loftsson T. 2007. Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliv Rev 59:645-666.
2. Carrier RL, Miller LA, Ahmed I. 2007. The utility of cyclodextrins for enhancing oral bioavailability. J Control Release 123:78-99.
3. Matilainen L, Larsen KL, Wimmer R, Keski-Rahkonen P, Auriola S, Järvinen T, Jarho P. 2008. The effect of cyclodextrins on chemical and physical stability of glucagon and characterization of glucagon/γ-CD inclusion complexes. J Pharm Sci 97:2720-2729.
4. Davis ME, Brewster ME. 2004. Cyclodextrin-based pharmaceutics: Past, present and future. Nat Rev Drug Discov 3:1023-1035.
5. Harata K. 1998. Structural aspects of stereodifferentiation in the solid state. Chem Rev 98:1803-1827.
6. Rusa CC, Bullions TA, Fox J, Porbeni FE, Wang X, Tonelli AE. 2002. Inclusion compound formation with a new columnar cyclodextrin host. Langmuir 18:10016-10023.
7. Hunt MA, Rusa CC, Tonelli AE, Balikb CM. 2005. Structure and stability of columnar cyclomaltooctaose (γ-cyclodextrin) hydrate. Carbohydr Res 340:1631-1637.
8. Nakai Y, Yamamoto K, Terada K, Kajiyama A, Sasaki I. 1986. Properties of crystal water of α-, β- and γ-cyclodextrin. Chem Pharm Bull 34:2178-2182.
9. Takeo K, Kuge T. 1970. Complexes of starchy materials with organic compounds Part IV. X-ray diffraction of γ-cyclodextrin complexes. Agric Biol Chem 34:568-574.
10. Uyar T, Hunt MA, Gracz HS, Tonelli AE. 2006. Crystalline cyclodextrin inclusion compounds formed with aromatic guests: Guest-dependent stoichiometries and hydration-senseitive crystal structures. Cryst Growth Des 5:1113-1119.
11. Kawasaki J, Satou D, Takagaki T, Nemoto T, Kawaguchi A. 2007. Structural features of inclusion complexes of γ-cyclodextrin with various polymers. Polymer 48:1127-1138.
12. Williams RO III, Liu J. 1999. Influence of formulation technique for hydroxypropyl-γ-cyclodextrin on the stability of aspirin in HFA 134a. Eur J Pharm Biopharm 47:145-152.
13. Fernandes CM, Vieira MT, Veiga FJB. 2002. Physicochemical characterization and in vitro dissolution behavior of nicardipine-cyclodextrins inclusion compounds. Eur J Pharm Sci 15:79-88.
14. Miller LA, Carrier RL, Ahmed I. 2007. Practical considerations in development of solid dosage forms that contain cyclodextrin. J Pharm Sci 96:1691-1707.
15. Moribe K, Sekiya N, Fujito T, Yamamoto M, Higashi K, Yokohama C, Tozuka Y, Yamamoto K. 2007. Stabilization mechanism of limaprost in solid dosage form. Int J Pharm 338:1-6.
16. Moribe K, Fujito T, Tozuka Y, Yamamoto K. 2007. Solubility-dependent complexation of active pharmaceutical ingredients with trimethyl-β- cyclodextrin under supercritical fluid condition. J Incl Phenom Macrocycl Chem 57:289-295.
17. Limwikrant W, Higashi K, Yamamoto K, Moribe K. 2009. Characterization of ofloxacin-oxalic acid complex by PXRD, NMR, and THz spectroscopy. Int J Pharm 382:50-55.
18. Nakai Y, Yamamoto K, Terada K, Watanabe D. 1987. New methods for preparing cyclodextrin inclusion compounds I. Heating in a sealed container. Chem Pharm Bull 35:4609-4615.
19. Watanabe D, Ohta M, Yang ZJ, Yonemochi E, Oguchi T, Yamamoto K. 1996. Formation of a heptais-(2,6-di-O-methyl)-β-cyclodextrin-p-nitrophenol inclusion compound by sealed-heating. Chem Pharm Bull 44:833-836.
20. Uchino T, Tozuka Y, Oguchi T, Yamamoto K. 2002. Inclusion compound formation of amylose by sealed-heating with salicylic acid analogues. J Incl Phenom Macrocycl Chem 43:31-36.
21. Oguchi T, Kazama K, Yonemochi E, Churimaworapan S, Choi W, Limmatvapirat S, Yamamoto K. 2000. Specific complexation of ursodeoxycholic acid with guest compounds induced by co-grinding. Phys Chem Chem Phys 2:2815-2820.
22. Moribe K, Tsuchiya M, Tozuka Y, Yamaguchi K, Oguchi T, Yamamoto K. 2004. Grinding-induced equimolar complex formation between thiourea and ethenzamide. Chem Pharm Bull 52:524-529.
23. Nakai Y, Yamamoto K, Terada K, Oguchi T, Saito H, Watanabe D. 1989. New methods for preparing cyclodextrin inclusion compounds II. Effects of heating temperature, water contents and drug properties on the inclusion formation. Chem Pharm Bull 37:1055-1058.
24. Higashi K, Ideura S, Waraya H, Moribe K, Yamamoto K. 2009. Incorporation of salicylic acid molecules into the intermolecular spaces of γ-cyclodextrin-polypseudorotaxane. Cryst Growth Des 9:4243-4246.
25. 2, the organic additives 1-propanol, 2-propanol, and the surfactant sodium dodecyl sulfate. J Phys Chem B 106:4763-4774.
26. Nakai Y, Nakajima S, Yamamoto K, Terada K, Konnno T. 1980. Effects of grinding on physical and chemical properties of crystalline medicinals with microcrystalline cellulose IV. Comparison of the IR spectra of medicinals in the solid state and in solution. Chem Pharm Bull 28:652-656.
27. Tozuka Y, Oguchi T, Yamamoto K. 2003. Adsorption and entrapment of salicylamide molecules into the mesoporous structure of folded sheets mesoporous material (FSM-16). Pharm Res 20:926-931.
28. Geppi M, Mollica G, Borsacchi S, Veracini CA. 2008. Solid-state NMR studies of pharmaceutical systems. Appl Spectrosc Rev 43:202-302.
29. Pongpeerapat A, Higashi K, Tozuka Y, Moribe K, Yamamoto K. 2006. Molecular interaction among probucol/PVP/SDS multi-component system investigated by solid-state NMR. Pharm Res 23:2566-2574.
30. Nishiwaki A, Watanabe A, Higashi K, Tozuka Y, Moribe K, Yamamoto K. 2009. Molecular states of prednisolone dispersed in folded sheet mesoporous silica; FSM-16. Int J Pharm 378:17-22.
31. Oguchi T, Yamasato H, Limmatvapirat S, Yonemochi E, Yamamoto K. 1998. Structural change and complexation of strictly linear amylose induced by sealed-heating with salicylic acid. J Chem Soc Faraday Trans 94:923-927.
32. Harata K. 1988. The structure of the cyclodextrin complex. XXI. Crystal structures of hepatakis(2,6-di-O-methyl)-β-cyclodextrin complexes with p-iodophenol and p-nitrophenol. Bull Chem Soc Jpn 61:1939-1944.
33. Uyar T, Rusa CC, Hunt MA, Aslan E, Hacaloglu J, Tonelli AE. 2005. Reorganization and improvement of bulk polymers by processing with their cyclodextrin inclusion compounds. Polymer 46:4762-4775.
34. Harata K, Uedaira H, Tanaka J. 1978. The structure of the cyclodextrin complex. VI. The crystal structure of α-cyclodextrin-m-nitrophenol (1:2) complex. Bull Chem Soc Jpn 51:1627-1634.
35. Kamitori S, Toyama Y, Matsuzaka O. 2001. Crystal structures of cyclomaltohexaose (α-cyclodextrin) complexes with p-bromophenol and m-bromophenol. Carbohydr Res 332:235-240.
36. 12 with Z′ = 3/4: Crystal structure of the complex γ-cyclodextrin-methanol-n-hydrate. Acta Cryst B54:450-455.
37. Szejtli J. 2004. Past, present, and future of cyclodextrin research. Pure Appl Chem 76:1825-1845.
38. Ikeda Y, Hirayama F, Arima H, Uekama K, Yoshitake Y, Harano K. 2004. NMR spectroscopic characterization of metoprolol/cyclodextrin complexes in aqueous solution: Cavity size dependency. J Pharm Sci 93:1659-1671.
39. Toropainen T, Heikkilä T, Leppänen J, Matilainen L, Velaga S, Jarho P, Carlfors J, Lehto V, Jarvinen T, Järvinen K. 2007. Crystal structure changes of γ-cyclodextrin after the SEDS process in supercritical carbon dioxide affect the dissolution rate of complexed budesonide. Pharm Res 24:1058-1066.
40. Messner M, Kurkov SV, Jansook P, Loftsson T. 2010. Self-assembled cyclodextrin aggregates and nanoparticles. Int J Pharm 387:199-208.